ONLINE DATABASE SEARCH - HIV-LS-308-MEMO
1. 44289 HIV-LS-308; PUBMED-HIV-11/4/2004
MECHANISM-BASED INACTIVATION OF CYTOCHROME P450 3A (CYP3A) BY HIV PROTEASE INHIBITORS
Ernest, Ii CS, Hall, SD, and Jones, DR
J Pharmacol Exp Ther 2004.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15523003&dopt=abstract
2. 44290 HIV-LS-308; PUBMED-HIV-11/4/2004
Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides
Masuda, N, Yamamoto, O, Fujii, M, Ohgami, T, Fujiyasu, J, Kontani, T, Moritomo, A, Orita, M, Kurihara, H, Koga, H, Nakahara, H, Kageyama, S, Ohta, M, Inoue, H, Hatta, T, Suzuki, H, Sudo, K, Shimizu, Y, Kodama, E, Matsuoka, M, Fujiwara, M, Yokota, T, Shigeta, S, and Baba, M
Bioorg Med Chem 2004. 12(23): 6171-82
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15519161&dopt=abstract
3. 44291 HIV-LS-308; PUBMED-HIV-11/4/2004
In Vitro Combination of Amdoxovir and the Inosine Monophosphate Dehydrogenase Inhibitors Mycophenolic Acid and Ribavirin Demonstrates Potent Activity against Wild-Type and Drug-Resistant Variants of Human Immunodeficiency Virus Type 1
Borroto-Esoda, K, Myrick, F, Feng, J, Jeffrey, J, and Furman, P
Antimicrob Agents Chemother 2004. 48(11): 4387-94
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15504868&dopt=abstract
4. 44292 HIV-LS-308; PUBMED-HIV-11/4/2004
N-Substituted Pyrrole Derivatives as Novel Human Immunodeficiency Virus Type 1 Entry Inhibitors That Interfere with the gp41 Six-Helix Bundle Formation and Block Virus Fusion
Jiang, S, Lu, H, Liu, S, Zhao, Q, He, Y, and Debnath, AK
Antimicrob Agents Chemother 2004. 48(11): 4349-59
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15504864&dopt=abstract
5. 44293 HIV-LS-308; EMBASE-HIV-11/4/2004
In vitro synthesis of enzymatically active HIV-1 protease for rapid phenotypic resistance profiling
Hoffmann, Dieter, Buchberger, Bernd, and Nemetz, Cordula
Journal of Clinical Virology 2004. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6VJV-4DJ4W65-1/2/84ba6fb2c7b5b20c71dd1c43532e39a7
6. 44294 HIV-LS-308; EMBASE-HIV-11/4/2004
Adaptive inhibitors of the HIV-1 protease
Ohtaka, Hiroyasu and Freire, Ernesto
Progress in Biophysics and Molecular Biology 2004. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TBN-4DH29MG-1/2/00541d0de5226a8c62ac0544acd4e865
7. 44295 HIV-LS-308; PUBMED-HIV-11/4/2004
A mechanistic study of 3-aminoindazole cyclic urea HIV-1 protease inhibitors using comparative QSAR
Garg, R and Bhhatarai, B
Bioorg Med Chem 2004. 12(22): 5819-31
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15498658&dopt=abstract
8. 44296 HIV-LS-308; PUBMED-HIV-11/4/2004
A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity
Hertel, J, Struthers, H, Baird, Horj C, and Hruz, PW
J Biol Chem 2004.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15496402&dopt=abstract
9. 44297 HIV-LS-308; PUBMED-HIV-11/4/2004
The impact of the M184V substitution on drug resistance and viral fitness
Wainberg, MA
Expert Rev Anti Infect Ther 2004. 2(1): 147-51
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15482179&dopt=abstract
10. 44298 HIV-LS-308; PUBMED-HIV-11/4/2004
Atazanavir: improving the HIV protease inhibitor class
Becker, S
Expert Rev Anti Infect Ther 2003. 1(3): 403-13
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15482137&dopt=abstract
11. 44299 HIV-LS-308; PUBMED-HIV-11/4/2004
The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets
Turpin, JA
Expert Rev Anti Infect Ther 2003. 1(1): 97-128
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15482105&dopt=abstract
12. 44300 HIV-LS-308; EMBASE-HIV-11/4/2004
Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors
Stein, James H, Merwood, Michelle A, Bellehumeur, Jennifer L, Aeschlimann, Susan E, Korcarz, Claudia E, Underbakke, Gail L, Mays, Maureen E, and Sosman, James M
American Heart Journal 2004. 147(4): 713
HYPERLINK:
http://www.sciencedirect.com/science/article/B6W9H-4C40S52-1H/2/8f6cec51a0f5ba401b331a70af6bd239
13. 44301 HIV-LS-308; PUBMED-HIV-11/4/2004
Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor
King, NM, Prabu-Jeyabalan, M, Nalivaika, EA, Wigerinck, P, de, Bethune MP, and Schiffer, CA
J Virol 2004. 78(21): 12012-21
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15479840&dopt=abstract
14. 44302 HIV-LS-308; PUBMED-HIV-11/4/2004
Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase
Desjobert, C, de Soultrait, VR, Faure, A, Parissi, V, Litvak, S, Tarrago-Litvak, L, and Fournier, M
Biochemistry 2004. 43(41): 13097-13105
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15476403&dopt=abstract
15. 44303 HIV-LS-308; PUBMED-HIV-11/4/2004
Purification of a novel ribonuclease from dried fruiting bodies of the edible wild mushroom Thelephora ganbajun
Wang, HX and Ng, TB
Biochem Biophys Res Commun 2004. 324(2): 855-9
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15474506&dopt=abstract
16. 44304 HIV-LS-308; WOS-HIV-10/25/2004
Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif
Feng, F, Davis, A, Lake, JA, Carr, J, Xia, W, Burrell, C, and Li, P
JOURNAL OF VIROLOGY 2004. 78(19): 10574-10581, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223964300039
17. 44305 HIV-LS-308; WOS-HIV-10/25/2004
GW-873140 - Anti-HIV therapy HIV entry inhibitor CCR5 antagonist
McIntyre, JA
DRUGS OF THE FUTURE 2004. 29(7): 677-679, 3
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223948800002
18. 44306 HIV-LS-308; WOS-HIV-10/25/2004
Effective inhibition of HIV-1 replication in cultured cells by external guide sequences and ribonuclease P
Barnor, JS, Endo, Y, Habu, Y, Miyano-Kurosaki, N, Kitano, M, Yamamoto, H, and Takaku, H
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2004. 14(19): 4941-4944, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224013000027
19. 44307 HIV-LS-308; WOS-HIV-10/25/2004
Synthesis of enantiomerically pure D-FDOC, an anti-HIV agent
Mao, SL, Bouygues, M, Welch, C, Biba, M, Chilenski, J, Schinazi, RF, and Liotta, DC
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2004. 14(19): 4991-4994, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224013000037
20. 44308 HIV-LS-308; WOS-HIV-10/31/2004
Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses
Wolinsky, SM, Veazey, RS, Kunstman, KJ, Klasse, PJ, Dufour, J, Marozsan, AJ, Springer, MS, and Moore, JP
VIROLOGY 2004. 328(1): 19-29, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224117300003
21. 44309 HIV-LS-308; WOS-HIV-10/31/2004
Efficiency of a second-generation HIV-1 protease inhibitor studied by molecular dynamics and absolute binding free energy calculations
Lepsik, M, Kriz, Z, and Havlas, Z
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS 2004. 57(2 ): 279-293, 15
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223926200005
22. 44310 HIV-LS-308; WOS-HIV-10/31/2004
Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction
Colombo, S, Guignard, N, Marzolini, C, Telenti, A, Biollaz, J, and Decosterd, LA
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 2004. 810(1): 25-34, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224010000004
23. 44311 HIV-LS-308; WOS-HIV-10/31/2004
The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1
Daly, NL, Gustafson, KR, and Craik, DJ
FEBS LETTERS 2004. 574(1-3): 69-72, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224041600012
24. 44312 HIV-LS-308; WOS-HIV-10/31/2004
Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(I-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4-oxadiazoline-2-thiones
El-Emam, AA, Al-Deeb, OA, Al-Omar, M, and Lehmann, J
BIOORGANIC & MEDICINAL CHEMISTRY 2004. 12(19): 5107-5113, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224014000009